Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | -5.92% | -5.92% | -42.60% |
03-18 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
03-15 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2024 * | 40.7M 3.25B | Sales 2025 * | 49.94M 3.99B | Capitalization | 8.09M 646M |
---|---|---|---|---|---|
Net income 2024 * | -16M -1.28B | Net income 2025 * | -3M -239M | EV / Sales 2024 * | 0.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.16 x |
P/E ratio 2024 * |
-0.49
x | P/E ratio 2025 * |
-2.92
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.65% |
Latest transcript on Biofrontera Inc.
1 day | -5.92% | ||
1 week | -5.92% | ||
Current month | +3.25% | ||
1 month | +3.25% | ||
3 months | +5.30% | ||
6 months | -56.44% | ||
Current year | -42.60% |
Managers | Title | Age | Since |
---|---|---|---|
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 28/02/15 |
Fred Leffler
DFI | Director of Finance/CFO | 41 | 23/10/22 |
Erica Gates
DFI | Director of Finance/CFO | - | 31/07/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Borer
BRD | Director/Board Member | 67 | 01/11/21 |
Hermann Lübbert
CEO | Chief Executive Officer | 68 | 28/02/15 |
Kevin D. Weber
BRD | Director/Board Member | 66 | 01/03/22 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.59 | -5.92% | 50,733 |
25/04/24 | 1.69 | +1.81% | 26,034 |
24/04/24 | 1.66 | +11.04% | 62,969 |
23/04/24 | 1.495 | +3.46% | 54,109 |
22/04/24 | 1.445 | -14.50% | 93,931 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.60% | 8.09M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BFRI Stock